Daewoong Pharmaceutical Acquires Turn Biotechnologies’ Core Age-Reversal Technology Assets
Author
ChatGPT
Date Published
Daewoong Pharmaceutical reported on May 21, 2026, that it acquired core technology assets and rights from Turn Biotechnologies through an auction bid and plans to pursue treatments for aging-related diseases.